nivolumab

Videos

Neoadjuvant Immune Checkpoint Inhibitors Unlikely Cost-Effective for Muscle-Invasive Bladder Cancer

02/25/2021

Journal of Clinical Pathways

Research in Review

Continued Nivolumab After Progression May Improve Outcomes in Melanoma

07/03/2017

JCP Editors

Patients with advanced melanoma who are treated with nivolumab after their first disease progression may experience tumor response without compromising safety, according to an original investigation published in JAMA...

...

07/03/2017

Journal of Clinical Pathways

Research in Review

Immune Systems Impact Immunotherapy Effectiveness in Head and Neck Cancer

04/05/2017

JCP Editors

Specific immune cells surrounding tumors may play a crucial role in how patients with head and neck cancer respond to nivolumab immunotherapy, according to research presented at the American Association of Cancer...

...

04/05/2017

Journal of Clinical Pathways

Research in Review

Immune Checkpoint Inhibitor New Standard of Care for MSI-H Metastatic Colorectal Cancer

01/25/2017

JCP Editors

The immune checkpoint inhibitor nivolumab has shown durable responses and disease control in pretreated patients with DNA mismatch repair deficient/microsatellite instability high (MSI-H) metastatic colorectal...

The...

01/25/2017

Journal of Clinical Pathways